US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)
Scope of the Report
The report entitled “US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)”, provides analysis of the US lymphedema market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by players, etc.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2016-2020, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
Tactile is the only company providing the Advanced PC device, named Flexitouch. The other key companies in the market are Bio Compression System, Wright Therapy Products and Lympha Press, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage
Lymphedema is when excess lymphatic fluid gets collected in the tissues under the skin, which causes swelling. Generally, lymphedema occurs due to the damage or removal of lymph nodes, as a part of cancer surgery.
Lymphedema can be divided into 4 stages, based on the swelling it causes and its severity. There are two types of lymphedema: Primary Lymphedema and Secondary Lymphedema. Primary lymphedema is detected in the children and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs due to the cancer treatment or surgery, resulting in the removal of lymph nodes.
There are many options of treatment of lymphedema available today. These can be used as a single option, and/or in combinations. Treatment of Lymphedema includes: Controlled Compression Therapy, Manual Lymph Drainage (MLD), Complete Decongestive Therapy (CDT) and Pneumatic Compression (PC). PCD are the devices which deliver intermittent pressure through varying inflation and deflation chambers, to move the lymph fluid from extremity and to avoid the adverse consequences of uncontrolled lymphedema.
The US lymphedema market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The US lymphedema market is supported by various growth drivers, such as increasing per capita healthcare expenditure in the US, sever long term effects of non treatment of lymphedema, increasing cancer cases every year, etc. Yet, the market faces certain challenges, such as, reimbursement issues, low awareness, etc.
The report entitled “US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)”, provides analysis of the US lymphedema market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by players, etc.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2016-2020, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
Tactile is the only company providing the Advanced PC device, named Flexitouch. The other key companies in the market are Bio Compression System, Wright Therapy Products and Lympha Press, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage
- Tactile Medical
- Bio Compression System
- Lympha Press (Mego Afek)
- Wright Therapy Products (BSN Medical)
Lymphedema is when excess lymphatic fluid gets collected in the tissues under the skin, which causes swelling. Generally, lymphedema occurs due to the damage or removal of lymph nodes, as a part of cancer surgery.
Lymphedema can be divided into 4 stages, based on the swelling it causes and its severity. There are two types of lymphedema: Primary Lymphedema and Secondary Lymphedema. Primary lymphedema is detected in the children and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs due to the cancer treatment or surgery, resulting in the removal of lymph nodes.
There are many options of treatment of lymphedema available today. These can be used as a single option, and/or in combinations. Treatment of Lymphedema includes: Controlled Compression Therapy, Manual Lymph Drainage (MLD), Complete Decongestive Therapy (CDT) and Pneumatic Compression (PC). PCD are the devices which deliver intermittent pressure through varying inflation and deflation chambers, to move the lymph fluid from extremity and to avoid the adverse consequences of uncontrolled lymphedema.
The US lymphedema market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The US lymphedema market is supported by various growth drivers, such as increasing per capita healthcare expenditure in the US, sever long term effects of non treatment of lymphedema, increasing cancer cases every year, etc. Yet, the market faces certain challenges, such as, reimbursement issues, low awareness, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Lymphedema: An Overview
2.2 Types of Lymphedema
2.3 Treatment of Lymphedema
3. MARKET ANALYSIS
3.1 US Lymphedema Market: An Analysis
3.1.1 US Lymphedema Market by Number of Patients
3.1.2 US Lymphedema Market by Number of Patients Diagnosed
3.1.3 US Lymphedema Market by Diagnosed Patients Severity
3.1.4 US Lymphedema Market by Total Addressable Market (TAM)
3.2 US Lymphedema Market: Patient Analysis
3.2.1 US Lymphedema Patients by Causes
3.2.2 US Lymphedema Patients by Demographics
3.3 US Lymphedema Pneumatic Compression Device (PCD) Market: An Analysis
3.3.1 US PCD Market by Case Adoption
3.3.2 US PCD Market by ASP
3.3.3 US PCD Market by Value
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Per Capita Healthcare Expenditure in the US
4.1.2 Increasing Obese Population
4.1.3 Increasing Cancer Cases
4.1.4 Long Term Effects Increase the Demand for PCD Devices
4.2 Challenges
4.2.1 Reimbursement Issues
4.2.2 Improvement in Treatment of Cancer
4.2.3 Low Awareness
4.3 Market Trends
4.3.1 At-home Treatment
4.3.2 Cost Effectiveness of Flexitouch
4.3.3 Effects of Exercise
4.3.4 Evolving Treatment Options for Lymphedema
5. COMPETITIVE LANDSCAPE
5.1 US PCD Market Share by Players
5.2 US PCD Comparison by Players
6. COMPANY PROFILING
6.1 Tactile Systems Technology
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Bio Compression System
6.2.1 Business Overview
6.2.2 Business Strategy
6.3 Lympha Press (Mego Afek)
6.3.1 Business Overview
6.3.2 Business Strategy
6.4 Wright Therapy Products, Inc. (BSN Medical)
6.4.1 Business Overview
6.4.2 Business Strategy
2. INTRODUCTION
2.1 Lymphedema: An Overview
2.2 Types of Lymphedema
2.3 Treatment of Lymphedema
3. MARKET ANALYSIS
3.1 US Lymphedema Market: An Analysis
3.1.1 US Lymphedema Market by Number of Patients
3.1.2 US Lymphedema Market by Number of Patients Diagnosed
3.1.3 US Lymphedema Market by Diagnosed Patients Severity
3.1.4 US Lymphedema Market by Total Addressable Market (TAM)
3.2 US Lymphedema Market: Patient Analysis
3.2.1 US Lymphedema Patients by Causes
3.2.2 US Lymphedema Patients by Demographics
3.3 US Lymphedema Pneumatic Compression Device (PCD) Market: An Analysis
3.3.1 US PCD Market by Case Adoption
3.3.2 US PCD Market by ASP
3.3.3 US PCD Market by Value
4. MARKET DYNAMICS
4.1 Growth Drivers
4.1.1 Rising Per Capita Healthcare Expenditure in the US
4.1.2 Increasing Obese Population
4.1.3 Increasing Cancer Cases
4.1.4 Long Term Effects Increase the Demand for PCD Devices
4.2 Challenges
4.2.1 Reimbursement Issues
4.2.2 Improvement in Treatment of Cancer
4.2.3 Low Awareness
4.3 Market Trends
4.3.1 At-home Treatment
4.3.2 Cost Effectiveness of Flexitouch
4.3.3 Effects of Exercise
4.3.4 Evolving Treatment Options for Lymphedema
5. COMPETITIVE LANDSCAPE
5.1 US PCD Market Share by Players
5.2 US PCD Comparison by Players
6. COMPANY PROFILING
6.1 Tactile Systems Technology
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Bio Compression System
6.2.1 Business Overview
6.2.2 Business Strategy
6.3 Lympha Press (Mego Afek)
6.3.1 Business Overview
6.3.2 Business Strategy
6.4 Wright Therapy Products, Inc. (BSN Medical)
6.4.1 Business Overview
6.4.2 Business Strategy
LIST OF FIGURES
Figure 1: Type of Lymphedema
Figure 2: Treatment of Lymphedema
Figure 3: Total US Population; 2015-2020 (Million)
Figure 4: US Lymphedema Market by Number of Patients and Penetration; 2015-2020
Figure 5: US Lymphedema Market by Number of Patients Diagnosed; 2015-2020
Figure 6: US Lymphedema Market by Number of Diagnosed Patients Severity; 2015-2020
Figure 7: US Lymphedema Market by Total Addressable Market (TAM); 2015-2020 (US$ Million)
Figure 8: US Lymphedema Patients by Causes
Figure 9: US Lymphedema Patients by Gender
Figure 10: US Lymphedema Patients by Age Group
Figure 11: US PCD Market by Case Adoption; 2016-2020
Figure 12: US PCD Market by ASP; 2015-2020
Figure 13: US PCD Market by Value; 2016-2020 (US$ Million)
Figure 14: US Per Capita Healthcare Expenditure; 2007-2014 (US$)
Figure 15: Percentage of Obese Population (Above 20 Years) in the US; 1999-2014
Figure 16: New Cancer Cases in the US; 2015
Figure 17: US PCD Market Share by Players; 2016-2020
Figure 18: Tactile Revenue; 2013-2016E (US$ Million)
Figure 19: Tactile Revenue by Segments; 2015
Table 1: Lymphedema Classification Scale
Table 2: Pneumatic Compression Pump/ Device Comparison by Players
Figure 1: Type of Lymphedema
Figure 2: Treatment of Lymphedema
Figure 3: Total US Population; 2015-2020 (Million)
Figure 4: US Lymphedema Market by Number of Patients and Penetration; 2015-2020
Figure 5: US Lymphedema Market by Number of Patients Diagnosed; 2015-2020
Figure 6: US Lymphedema Market by Number of Diagnosed Patients Severity; 2015-2020
Figure 7: US Lymphedema Market by Total Addressable Market (TAM); 2015-2020 (US$ Million)
Figure 8: US Lymphedema Patients by Causes
Figure 9: US Lymphedema Patients by Gender
Figure 10: US Lymphedema Patients by Age Group
Figure 11: US PCD Market by Case Adoption; 2016-2020
Figure 12: US PCD Market by ASP; 2015-2020
Figure 13: US PCD Market by Value; 2016-2020 (US$ Million)
Figure 14: US Per Capita Healthcare Expenditure; 2007-2014 (US$)
Figure 15: Percentage of Obese Population (Above 20 Years) in the US; 1999-2014
Figure 16: New Cancer Cases in the US; 2015
Figure 17: US PCD Market Share by Players; 2016-2020
Figure 18: Tactile Revenue; 2013-2016E (US$ Million)
Figure 19: Tactile Revenue by Segments; 2015
Table 1: Lymphedema Classification Scale
Table 2: Pneumatic Compression Pump/ Device Comparison by Players
